The Path to Integral Healthcare

Q: One of B. Braun Medical’s pillars since its founding has been innovation. How does that translate to an added value for its customers?

A: B. Braun Medical has been operating in Mexico for around six years and is continuously bringing innovation to the market. The added value of our business is based on the combination of more than 5,000 products and services that optimize our customers’ processes. Our combination of hardware and software guarantees the ability to monitor patients and their treatment. Our services contribute to helping hospitals improve their healthcare outcomes.

B. Braun Medical is highly focused on the patient-centric approach, with strong emphasis in oncology, intensive care and outpatient therapies. It cooperates with doctors, nurses, hospitals and other players in the health industry.

Q: COFEPRIS has indicated that one of the government’s objectives is to enter alliances with other regulatory agencies. What would B. Braun Medical like to see this regard?

A: There have been significant changes aimed at accelerating COFEPRIS’ processes and to deregulate certain products so that innovation reaches Mexico faster. At a local level, there is a need for companies and regulatory authorities to increase the competitiveness of products. In Mexico, there is a considerable amount of global and transnational companies that invest in the production and export of a wide variety of disposables, medical supplies and devices for the international market. National companies must improve their level of competitiveness and one way to achieve this is by raising COFEPRIS’ regulatory requirements to meet international criteria. This will allow Mexican companies to be more competitive and to expand.

Q: How does B. Braun Medical ensure the effectiveness of its products in the Mexican health system?

A: All our products are of high quality, with the “Made in Germany” stamp, which provides a level of reliability to our customers. Therein lies the great added value of B. Braun Medical, in that we become advisers and clinicalcommercial partners to our clients, offering an integral consultancy of process optimization, through our offer that integrates medicines, medical equipment and software, who take special care regarding the safety of the patient and the health professionals who work within the hospital.

Q: How does the company ensure its most innovative products are quickly adapted by hospitals and doctors?

A: By developing unique solutions for each type of client, mostly hospitals and ambulatory care clinics. We have to understand the status quo of the client, the strategic priorities that a hospital has and based on this prepare an offer of our different solutions that add value to their operations. The challenge we have as B. Braun Medical is to accompany hospitals so they can adopt this innovation and turn it into improvements in their processes, with the advantage that all the innovation we offer makes an excellent match with the evolution and transformation of healthcare in the private and public sectors, which increasingly require more accurate measurement of patient outcomes.

Q: What percentage of your offer in Mexico goes to the public and private sectors?

A: Our distribution is directed 60 percent to the public sector and 40 percent to the private sector. About 95 percent of the products we sell in Mexico are imported from different parts of the world. We want to improve access to international and premium products and services, since patients are the same all over the world and require quality care.

For this, B. Braun develops new models of integral services for both sectors, which involve not only procedures in surgeries but also procedures in other areas of the hospital, moving from the sale of products to the sale of value-added services, considering that the government sector is ready to integrate these innovative service models.